Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/1990
07/19/1990CA2007878A1 Process for preparing non-tacky particles containing an organopolysiloxane compositiioin cured by polyaddition reactions
07/18/1990EP0378413A2 Compositions for topical treatment of skin disorders
07/18/1990EP0378403A2 Dispensing devices powered by lyotropic liquid crystals
07/18/1990EP0378208A2 Production method for protein-containing composition
07/18/1990EP0378172A1 Surface-treated sodium bicarbonate particle and molded preparation thereof
07/18/1990EP0378086A2 Use of the agent azelastine in the treatment of psoriasis
07/18/1990EP0377657A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3
07/17/1990US4942179 Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications
07/17/1990US4942175 Coccaine aversion by treatment with local anesthetic, tetracaine or procaine and a carrier of mannitol or inositol
07/17/1990US4942158 Drug delivery patch for steroid delivery through skin
07/17/1990US4942035 Polypeptides and noncrosslinked linear, branched or graft block copolymers with hydrophobic biodegradable part and hydrophilic part
07/17/1990CA1271900A1 Toxin conjugates
07/14/1990WO1990008138A1 Heterocyclic chelating agents
07/14/1990CA2045539A1 Heterocyclic chelating agents
07/13/1990CA2025018A1 Compositions containing thymopentin for topical treatment of skin disorders
07/13/1990CA2007545A1 Production method for protein-containing composition
07/12/1990WO1990007469A1 Pulmonary administration of pharmaceutically active substances
07/12/1990WO1990007345A1 Pharmaceutical preparation
07/12/1990WO1990007339A1 Treatment of iodine deficiency diseases
07/12/1990WO1990007336A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
07/12/1990WO1990007331A1 Anti-inflammatory liniment
07/12/1990WO1990007324A1 Pharmaceutical formulations
07/12/1990DE4000070A1 Azelastin for treating psoriasis and inflammatory disease - esp. ulcerative colitis, formulated for oral, topical or parenteral delivery
07/12/1990DE3900484A1 Foods, dietetic foods, food addtives and medicaments based on yeast and spent cereal mash
07/11/1990WO1990007931A1 Method of promoting hair growth by applying a blood platelet extract
07/11/1990EP0377520A2 Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
07/11/1990EP0377439A2 Controlled-release, low-dose aspirin
07/11/1990EP0377413A1 Pharmaceutical compositions having topical use comprising Ticlopidine
07/11/1990EP0377266A1 Diatomic iodine for the treatment of iodine deficiency diseases
07/11/1990EP0377147A2 Therapeutic transdermal system having physostigmine as the active ingredient, and process for its development
07/11/1990CN1043631A Composition for controlled release of polypeptides
07/11/1990CN1008724B Process for preparation of granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
07/11/1990CA2045144A1 Wound healing agents
07/10/1990US4940737 Chemically modified hydrophilic prepolymers and polymers
07/10/1990US4940586 Skin permeation enhancer compositions using sucrose esters
07/10/1990US4940579 Pressure sensitive polymeric adhesives
07/10/1990CA1271360A1 Enteral nutritional hypoallergenic formula
07/09/1990CA2005850A1 Surface-treated sodium bicarbonate particle and molded preparation thereof
07/05/1990DE3942131A1 Uncoated tablets for slow, zero order release of trimebutin - for treating gastrointestinal disorders, contg. hydroxypropyl methylcellulose matrix, tartaric acid and diluent
07/04/1990WO1990007344A1 Liquid sustained release composition
07/04/1990WO1990007343A1 Liquid orally administrable compositions based on edible oils
07/04/1990EP0376917A1 Pharmaceutical preparation
07/04/1990EP0376852A1 Microgranules essentially consisting of triglycerides of saturated fatty acids loaded with an active substance, and their topical therapeutical use
07/04/1990EP0376656A2 Absorbable coating and blend
07/04/1990EP0376534A1 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine
07/04/1990EP0376533A2 Topical application of medicament in a binder
07/04/1990EP0376176A2 Bispecific monoclonal antibody, its production and use
07/04/1990EP0375885A1 Aqueous elcatonin solution composition
07/04/1990EP0375785A1 Lipid composition having enough safety and strong surface activity
07/04/1990EP0375773A1 Topical hematoporphyrin
07/04/1990EP0375736A1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein
07/04/1990EP0205602B1 Method for the production of soft gelatine capsules
07/04/1990EP0164397B1 A buffered polyol-hormone mixture for use in chronic parenteral hormone administration
07/04/1990CA2045510A1 Liquid sustained release composition
07/04/1990CA2045488A1 Liquid orally administrable compositions based on edible oils
07/03/1990US4939239 Hyposensitization agent of cedar pollen antigen
07/03/1990US4939083 Carbohydrate specific to chronic myelogenous leukemia granulocytes
07/03/1990US4938984 Nutritive compositions containing fatty substances
07/03/1990US4938964 External dermatological composition
07/03/1990US4938959 Insoluble medicament for a local administration in a human or animal ear
07/03/1990US4938763 Biodegradable in-situ forming implants and methods of producing the same
07/03/1990CA1271138A1 Solid pharmaceutical preparation containing 9-deoxo- 11-deoxy-9,11-[imino[2-(2-methoxyethoxy) ethylidene]-oxy]-(9s)-erythromycin
06/1990
06/30/1990CA2006980A1 Pharmaceutical formulations
06/29/1990CA2006956A1 Pulmonary administration of pharmaceutically active substances
06/29/1990CA2006834A1 Microgranules carrying an active substance, essentially comprising a saturated fatty acid triglyceride and their use for topical treatments
06/28/1990WO1990007117A1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
06/28/1990WO1990006952A1 Chemically modified granulocyte colony stimulating factor
06/28/1990WO1990006948A1 Mammalian gap-43 compositions and methods of use
06/28/1990WO1990006774A1 Hindered linking agents and methods
06/28/1990WO1990006772A1 Novel monoclonal antibody to human carcinomas
06/28/1990WO1990006767A1 Polypeptide-polymer conjugates active in wound healing
06/28/1990WO1990006764A1 Use of basic amino acids to solubilize immunoglobulins
06/28/1990WO1990006763A1 Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
06/28/1990WO1990006762A1 Stabilized hydrophobic protein formulations
06/28/1990WO1990006752A1 Veterinary composition and a process for the preparation thereof
06/28/1990WO1990006746A1 Heat-dehydrated emulsion compositions
06/28/1990WO1990004967A3 Topical ointment
06/28/1990DE3843557A1 Transdermal therapeutic system for administering clenbuterol
06/28/1990DE3842191A1 Neutral fat mixture from butter and use thereof
06/28/1990CA2006188A1 Regulating peritoneal lymphatic drainage and uses therefor
06/27/1990EP0375662A2 Controlled-release rectal pharmaceutical preparation
06/27/1990EP0375610A2 Perfluoroalkylthioglycosides
06/27/1990EP0375562A2 Novel monoclonal antibody to human carcinomas
06/27/1990EP0375122A2 Stabilized sucralose complex
06/27/1990EP0374725A2 Transdermal therapeutic system having norpseudoephedrine as the active compound
06/27/1990EP0374311A1 Urease antigen product
06/27/1990EP0374257A1 STABLE INTERFERON $g(b) COMPOSITION
06/27/1990EP0374252A1 Injection-type hemostatic composition
06/27/1990EP0374218A1 Novel transdermal penetration enhancers
06/27/1990CA2006408A1 Bispecific monoclonal antibody, its production and use
06/26/1990US4937270 Water insoluble derivatives of hyaluronic acid
06/26/1990US4937234 Minerals in bioavailable form
06/26/1990US4937183 Therapy, diagnostis immunology
06/26/1990US4937079 Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
06/26/1990CA1270850A1 Solid composition for dispersion in an organic medium
06/26/1990CA1270761A1 Preparation of a composition based on a finely divided active principle of low water solubility
06/26/1990CA1270760A1 Process for treating dosage forms
06/22/1990CA2006629A1 Hindered linking agents and methods
06/22/1990CA2006496A1 Mammalian gap-43 compositions and methods of use
06/22/1990CA2006353A1 Monoclonal antibody to human carcinomas
1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 1712